Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AC-201 in moderate-to-severe plaque psoriasis
NCT06972888Phase 2Completed
- Sponsor
- Accro Bioscience
- Start
- Apr 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AC-201 in plaque psoriasis, sponsored by Accro Bioscience. Started Apr 2024; status: completed.
02
Drugs
AC-201
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT06972888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06972888.